Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Rie Maurer et al.|The Lancet Respiratory Medicine|2022Cited by 211
Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblastsKonstantin Tsoyi, Iván O. Rosas, Anthony J. Esposito et al.|Scientific Reports|2022Cited by 16